Dana Investment Advisors »

Neurocrine Biosciences shares owned by Dana Investment Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Dana Investment Advisors from 13F filings

Historical chart of Dana Investment Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Dana Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Dana Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.2M 37k 168.54
2019-06-30 $254k 3.0k 84.53

More positions owned by Dana Investment Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Tidal Trust I Dana Unco Eq Etf (DUNK)
Amazon (AMZN)
Lam Research Corp Com New (LRCX)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Visa Com Cl A (V)
Amphenol Corp Cl A (APH)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Servicenow (NOW)

View all positions for Dana Investment Advisors

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences